Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common Stock, $0.001 par value · CUSIP: 19459J104
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rubric Capital Management LP
Shares: 3,000,000.00 · Class: 9.34%
- David Rosen
Shares: 3,000,000.00 · Class: 9.34%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-048489
- Form type
- SCHEDULE 13G/A
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership